BID and acute lymphoblastic leukemia: This is further supported by our previous study showing that in MLL-rearranged ALL, prednisolone sensitization mediated by pan-BCL-2 family inhibitors was largely driven by the up-regulation of pro-apoptotic BID and BIM [27].